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Background: When cystic ﬁbrosis (CF) patients become chronically infected
with P. aeruginosa, constantly elevated speciﬁc immunoglobulin G (IgG) and im-
munoglobulin A (IgA) against P. aeruginosa are seen. We believe that P. aeruginosa
often colonizes and adapts in the paranasal sinuses, which later results in an
IgG elevation, years before establishing the chronic lung infection. We therefore
hypothesize that an early P. aeruginosa-sinusitis simultaneously causes a local rise
in the speciﬁc IgA in mucous secretions, preventing the adherence of P. aeruginosa,
thus inhibiting a local and a systemic immune response.
Material and Method: 108 CF patients were enrolled in this cross-sectional
study. Antibodies against P. aeruginosa standard antigen (St-Ag) and P. aeruginosa
alginate were measured in serum, saliva and nasal secretion by means of ELISA.
Results: Patients with chronic P. aeruginosa infection had high IgA and IgG
antibody responses against alginate and St-Ag. Patients intermittently colonised
with P. aeruginosa had a higher mean IgA St-Ag than CF patients with other
pathogens being 70−75% higher (P = 0.02). Patients intermittently colonised with
P. aeruginosa had a higher St-Ag “IgA saliva: IgG saliva ratio” compared with
chronically infected patients (P = 0.04) and compared with CF patients with other
pathogens (P = 0.02).
Conclusion: We present a cheap method with high sensitivity that early can
diagnose P. aeruginosa sinusitis and differentiate between patients chronically
infected, intermittently colonised with P. aeruginosa and other CF patients.
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Infection by P. aeruginosa usually occurs at some point during childhood, often
acquired from the environment, and once established can be difﬁcult to eradicate.
Early, aggressive treatment is key to keeping airways free of P. aeruginosa, however
this requires rapid identiﬁcation of this opportunistic pathogen by diagnostic
laboratories.
Although the use of real time PCR (RT-PCR) in diagnostic microbiology is
increasing, in CF microbiology diagnostics, culture-based methods still dominate.
Here, we describe a rapid DNA extraction method and assays for the quantitative
detection in patient samples of (1) all bacteria, (2) P. aeruginosa and (3) the
Liverpool epidemic strain (LES), using two different RT-PCR chemistries: SYBR
green and multiplex probe-based assays. Initial comparisons revealed that RT-PCR
can be up to 6 log units more sensitive when comparing copy number to colony
forming units identiﬁed on culture medium. Using >180 sputum and cough swabs
from both adult and children CF patients we have compared both these methods
to the existing culture-based methods in terms of sensitivity and time to result.
There was 100% concordance between the 3 methods in terms of bacterial status
of patients; however the time to result was dramatically reduced. 85% of adult
patients were found to be infected with P. aeruginosa and 90% of these had the
LES. Furthermore, ﬂuctuations in P. aeruginosa number could also be detected
using RT-PCR.
Rapid identiﬁcation and subsequent antibiotic treatment of P. aeruginosa could be
pivotal in prolonging infection-free airways in CF patients.
We acknowledge funding from the NIHR through the Liverpool Biomedical Re-
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The prevalence of the Liverpool, Manchester and Midlands 1 strains of Pseu-
domonas aeruginosa in UK CF centres was determined in a study conducted in
our national reference laboratory in 2004 [1]. The segregation of CF patients based
on infection “status” is widely practised, and though there is limited published
evidence for its success, it is believed to have reduced the transmission of shared
strains. Our laboratory routinely performs national surveillance of P. aeruginosa
from UK hospitals using “Variable Number Tandem Repeat” (VNTR) analysis [2].
In 2010 we discovered a cluster of isolates with the VNTR proﬁle 8, 3, 4, 5, 2, 3,
5, 2 with a variable ninth locus. In all, we received 38 isolates from 35 patients
across 23 hospitals with this proﬁle. Twenty-ﬁve were from CF patients, 10 from
non-CF patients and 3 from hospital taps. Both pulsed-ﬁeld gel electrophoresis
analysis, and PCR screening of the accessory genome supplied further evidence
that these isolates represent a single strain. The clinical relevance of this cluster
remains unclear. This VNTR proﬁle was ﬁrst noted in non-CF patients in 2006,
while the earliest detection in CF patients was in 2009, perhaps suggesting this
strain is currently adapting to the CF lung.
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Background: Pseudomonas aeruginosa is a major pathogen in the CF lung and
once established is impossible to eradicate. The highly transmissible Liverpool
Epidemic Strain (LES) was already widespread in the community prior to its
discovery. A previous study of non-LES isolates (2005−06) from a paediatric CF
unit, using Clondiag Array Tube genotyping, revealed a high prevalence of a single
clone (D). The aim of this study was to genotype more recent isolates (2009−11)
from non-LES patients within the paediatric and adult CF Units in Liverpool.
Methods: 37 isolates were analysed (22 from the paediatric unit and 15 from the
adult unit) using Array Tube genotyping. The formerly identiﬁed Clone D isolates
(6) were additionally genotyped by PFGE (using Spe1) and by RAPD-PCR.
Results: Of the 22 paediatric isolates 18 Clone types were identiﬁed with 3 (C, P
and A3) being found more than once. 13 clone types were identiﬁed from the 15
adult isolates with 2 types found in more than one patient. None of the more recent
isolates were clone D. Isolates identiﬁed previously as clone D using the Array
Tube system varied according to the other genotyping methods used (PFGE and
RAPD). There was some concordance between the groupings obtained using PFGE
and RAPD typing.
Conclusion: This study demonstrates that clone D was most likely transient in the
CF population. Regular surveillance, involving genotyping of P. aeruginosa isolated
from patients and the hospital environment, would be beneﬁcial in the identiﬁcation
of newly emerging problem strains and the prevention of transmission.
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